Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

456 ARTÍCULOS , VIENDO DEL 196 AL 210

A randomised controlled trial of the use of aromatherapy and hand massage to reduce disruptive behaviour in people with dementia

Fu CY, Moyle W, Cooke M.

BMC Complement Altern Med. 2013 Jul 10;13:165. doi: 10.1186/1472-6882-13-165.

Effects of dementia-care mapping on residents and staff of care homes: a pragmatic cluster-randomised controlled trial

van de Ven G, Draskovic I, Adang EM, Donders R, Zuidema SU, Koopmans RT, Vernooij-Dassen MJ.

PLoS One. 2013 Jul 2;8(7):e67325. doi: 10.1371/journal.pone.0067325. Print 2013.

The influence of vascular risk factors on cognitive decline in patients with dementia: a systematic review

Blom K, Emmelot-Vonk MH, Koek HL.

Maturitas. 2013 Oct;76(2):113-7. doi: 10.1016/j.maturitas.2013.06.011. Epub 2013 Jul 10.

The National Task Group on Intellectual Disabilities and Dementia Practices consensus recommendations for the evaluation and management of dementia in adults with intellectual disabilities

Moran JA, Rafii MS, Keller SM, Singh BK, Janicki MP; American Academy of Developmental Medicine and Dentistry; Rehabilitation Research and Training Center on Aging With Developmental Disabilities, University of Illinois at Chicago; American Association on Intellectual and Developmental Disabilities.

Mayo Clin Proc. 2013 Aug;88(8):831-40. doi: 10.1016/j.mayocp.2013.04.024. Epub 2013 Jul 10.

PET imaging in a case of the semantic variant of primary progressive aphasia

Küper M, Zöller M, Liebeskind S, Wiltfang J, Benninghoff J.

Fortschr Neurol Psychiatr. 2013 Jul;81(7):e14-6. doi: 10.1055/s-0033-1335612. Epub 2013 Jul 15.

The triple challenge of recruiting older adults with dementia and high medical acuity in skilled nursing facilities

Kolanowski A, Mulhall P, Yevchak A, Hill N, Fick D.

J Nurs Scholarsh. 2013 Dec;45(4):397-404. doi: 10.1111/jnu.12042. Epub 2013 Jul 16.

Nutrition and the risk of Alzheimer's disease

Hu N, Yu JT, Tan L, Wang YL, Sun L, Tan L.

Biomed Res Int. 2013;2013:524820. doi: 10.1155/2013/524820. Epub 2013 Jun 20.

Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis

Wilcock DM, Griffin WS.

J Neuroinflammation. 2013 Jul 16;10:84. doi: 10.1186/1742-2094-10-84.

Proteolytic cleavage of apolipoprotein E4 as the keystone for the heightened risk associated with Alzheimer's disease

Rohn TT.

Int J Mol Sci. 2013 Jul 17;14(7):14908-22. doi: 10.3390/ijms140714908.

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Utility in detection and characterization of mild cognitive impairment due to Alzheimer's disease

Karantzoulis S, Novitski J, Gold M, Randolph C.

Arch Clin Neuropsychol. 2013 Dec;28(8):837-44. doi: 10.1093/arclin/act057. Epub 2013 Jul 17.

Systematic review: Effective characteristics of nursing homes and other residential long-term care settings for people with dementia

Zimmerman S, Anderson WL, Brode S, Jonas D, Lux L, Beeber AS, Watson LC, Viswanathan M, Lohr KN, Sloane PD.

J Am Geriatr Soc. 2013 Aug;61(8):1399-409. doi: 10.1111/jgs.12372. Epub 2013 Jul 19.

Examining the value of lexical retrieval treatment in primary progressive aphasia: two positive cases

Henry ML, Rising K, DeMarco AT, Miller BL, Gorno-Tempini ML, Beeson PM.

Brain Lang. 2013 Nov;127(2):145-56. doi: 10.1016/j.bandl.2013.05.018. Epub 2013 Jul 17.

Dietary antioxidants, cognitive function and dementia--a systematic review

Crichton GE, Bryan J, Murphy KJ.

Plant Foods Hum Nutr. 2013 Sep;68(3):279-92. doi: 10.1007/s11130-013-0370-0.

Kampo formulations, chotosan, and yokukansan, for dementia therapy: existing clinical and preclinical evidence

Matsumoto K, Zhao Q, Niu Y, Fujiwara H, Tanaka K, Sasaki-Hamada S, Oka J.

J Pharmacol Sci. 2013;122(4):257-69. doi: 10.1254/jphs.13r03cr. Epub 2013 Jul 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias